| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | prostaglandin receptor activity | 3.20e-04 | 11 | 49 | 2 | GO:0004955 | |
| GeneOntologyMolecularFunction | prostanoid receptor activity | 3.83e-04 | 12 | 49 | 2 | GO:0004954 | |
| GeneOntologyMolecularFunction | icosanoid receptor activity | 6.93e-04 | 16 | 49 | 2 | GO:0004953 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 7.02e-04 | 441 | 49 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 7.03e-04 | 614 | 49 | 7 | GO:0140657 | |
| GeneOntologyMolecularFunction | long-chain fatty acid transmembrane transporter activity | 8.80e-04 | 18 | 49 | 2 | GO:0005324 | |
| Domain | SEA | 6.01e-04 | 14 | 49 | 2 | SM00200 | |
| Domain | ATPase_dyneun-rel_AAA | 6.01e-04 | 14 | 49 | 2 | IPR011704 | |
| Domain | AAA_5 | 6.01e-04 | 14 | 49 | 2 | PF07728 | |
| Domain | USP_CS | 6.91e-04 | 66 | 49 | 3 | IPR018200 | |
| Domain | USP_1 | 8.21e-04 | 70 | 49 | 3 | PS00972 | |
| Domain | UCH | 8.56e-04 | 71 | 49 | 3 | PF00443 | |
| Domain | USP_2 | 8.56e-04 | 71 | 49 | 3 | PS00973 | |
| Domain | USP_3 | 8.91e-04 | 72 | 49 | 3 | PS50235 | |
| Domain | USP_dom | 8.91e-04 | 72 | 49 | 3 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 8.91e-04 | 72 | 49 | 3 | IPR001394 | |
| Domain | SEA | 1.65e-03 | 23 | 49 | 2 | PS50024 | |
| Domain | SEA_dom | 1.65e-03 | 23 | 49 | 2 | IPR000082 | |
| Domain | EGF-like_CS | 4.82e-03 | 261 | 49 | 4 | IPR013032 | |
| Domain | EGF_2 | 5.09e-03 | 265 | 49 | 4 | PS01186 | |
| Domain | AAA+_ATPase | 6.38e-03 | 144 | 49 | 3 | IPR003593 | |
| Domain | AAA | 6.38e-03 | 144 | 49 | 3 | SM00382 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 8.34e-05 | 31 | 39 | 3 | M39851 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 1.01e-04 | 33 | 39 | 3 | MM15918 | |
| Pathway | BIOCARTA_CDC42RAC_PATHWAY | 1.55e-04 | 7 | 39 | 2 | MM1487 | |
| Pathway | BIOCARTA_CDC42RAC_PATHWAY | 2.07e-04 | 8 | 39 | 2 | M5291 | |
| Pathway | PID_FANCONI_PATHWAY | 2.92e-04 | 47 | 39 | 3 | M1 | |
| Pubmed | 3.15e-08 | 5 | 52 | 3 | 25843623 | ||
| Pubmed | 3.75e-07 | 10 | 52 | 3 | 17478428 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 12958310 | ||
| Pubmed | Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. | 2.19e-06 | 2 | 52 | 2 | 10973822 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 9334251 | ||
| Pubmed | Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. | 2.19e-06 | 2 | 52 | 2 | 2393399 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 11289722 | ||
| Pubmed | The MUC3 gene encodes a transmembrane mucin and is alternatively spliced. | 2.19e-06 | 2 | 52 | 2 | 10405327 | |
| Pubmed | 5.38e-06 | 653 | 52 | 8 | 22586326 | ||
| Pubmed | Expression of mucin 3 and mucin 5AC in arthritic synovial tissue. | 6.57e-06 | 3 | 52 | 2 | 18163520 | |
| Pubmed | Regulation of the Fanconi Anemia DNA Repair Pathway by Phosphorylation and Monoubiquitination. | 6.57e-06 | 3 | 52 | 2 | 34828369 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 10512748 | ||
| Pubmed | Dysregulation of Amphiregulin stimulates the pathogenesis of cystic lymphangioma. | 6.57e-06 | 3 | 52 | 2 | 33941693 | |
| Pubmed | Mislocalization of the MRN complex prevents ATR signaling during adenovirus infection. | 1.31e-05 | 4 | 52 | 2 | 19197236 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 20943970 | ||
| Pubmed | FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway. | 1.31e-05 | 4 | 52 | 2 | 18931676 | |
| Pubmed | ATR-ATRIP kinase complex triggers activation of the Fanconi anemia DNA repair pathway. | 3.28e-05 | 6 | 52 | 2 | 22258451 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 9647638 | ||
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 17526493 | ||
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 36563124 | ||
| Pubmed | 5.28e-05 | 1168 | 52 | 9 | 19946888 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 15456891 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 23993743 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 9.35e-05 | 719 | 52 | 7 | 35337019 | |
| Pubmed | Cdk12 is essential for embryonic development and the maintenance of genomic stability. | 9.79e-05 | 10 | 52 | 2 | 26658019 | |
| Pubmed | Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. | 1.20e-04 | 11 | 52 | 2 | 15758953 | |
| Pubmed | 1.20e-04 | 11 | 52 | 2 | 10803598 | ||
| Pubmed | HELQ promotes RAD51 paralogue-dependent repair to avert germ cell loss and tumorigenesis. | 1.43e-04 | 12 | 52 | 2 | 24005329 | |
| Pubmed | 1.69e-04 | 13 | 52 | 2 | 19064565 | ||
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | 1.79e-04 | 351 | 52 | 5 | 20453000 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | 2.05e-04 | 571 | 52 | 6 | 37167062 | |
| Pubmed | 2.05e-04 | 76 | 52 | 3 | 27542412 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 2.09e-04 | 363 | 52 | 5 | 14691545 | |
| Pubmed | 2.19e-04 | 197 | 52 | 4 | 31620119 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 2.20e-04 | 1105 | 52 | 8 | 35748872 | |
| Pubmed | 2.27e-04 | 15 | 52 | 2 | 19536649 | ||
| Pubmed | Cdk12 Regulates Neurogenesis and Late-Arising Neuronal Migration in the Developing Cerebral Cortex. | 2.27e-04 | 15 | 52 | 2 | 27073218 | |
| Pubmed | HORMAD1-dependent checkpoint/surveillance mechanism eliminates asynaptic oocytes. | 2.27e-04 | 15 | 52 | 2 | 22530760 | |
| Pubmed | 2.48e-04 | 81 | 52 | 3 | 12838346 | ||
| Pubmed | 2.60e-04 | 1442 | 52 | 9 | 35575683 | ||
| Pubmed | 2.60e-04 | 16 | 52 | 2 | 33495473 | ||
| Pubmed | 2.60e-04 | 16 | 52 | 2 | 22154759 | ||
| Pubmed | 2.99e-04 | 214 | 52 | 4 | 22199357 | ||
| Pubmed | 3.23e-04 | 622 | 52 | 6 | 14574404 | ||
| Pubmed | 3.23e-04 | 399 | 52 | 5 | 37536630 | ||
| Pubmed | A Chimeric Egfr Protein Reporter Mouse Reveals Egfr Localization and Trafficking In Vivo. | 3.30e-04 | 18 | 52 | 2 | 28494873 | |
| Pubmed | 3.58e-04 | 634 | 52 | 6 | 34591612 | ||
| Pubmed | 3.62e-04 | 225 | 52 | 4 | 12168954 | ||
| Pubmed | 3.69e-04 | 19 | 52 | 2 | 18711365 | ||
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 3.96e-04 | 95 | 52 | 3 | 27129302 | |
| Pubmed | 4.04e-04 | 419 | 52 | 5 | 15635413 | ||
| Pubmed | A multiprotein complex necessary for both transcription and DNA replication at the β-globin locus. | 4.52e-04 | 21 | 52 | 2 | 20808282 | |
| Pubmed | DNA-dependent phosphorylation of Chk1 and Claspin in a human cell-free system. | 4.97e-04 | 22 | 52 | 2 | 15707391 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 5.16e-04 | 104 | 52 | 3 | 31240132 | |
| Pubmed | Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases. | 5.44e-04 | 23 | 52 | 2 | 14715245 | |
| Pubmed | 5.46e-04 | 106 | 52 | 3 | 19394292 | ||
| Pubmed | 5.76e-04 | 453 | 52 | 5 | 29656893 | ||
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 5.76e-04 | 108 | 52 | 3 | 19531213 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 5.90e-04 | 974 | 52 | 7 | 28675297 | |
| Pubmed | 6.02e-04 | 1285 | 52 | 8 | 35914814 | ||
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 6.41e-04 | 262 | 52 | 4 | 36880596 | |
| Pubmed | 6.96e-04 | 26 | 52 | 2 | 35920200 | ||
| Pubmed | 7.48e-04 | 1014 | 52 | 7 | 32416067 | ||
| Pubmed | 7.51e-04 | 27 | 52 | 2 | 36915679 | ||
| Pubmed | TRAIP regulates replication fork recovery and progression via PCNA. | 7.51e-04 | 27 | 52 | 2 | 27462463 | |
| Pubmed | Intestinal NCoR1, a regulator of epithelial cell maturation, controls neonatal hyperbilirubinemia. | 7.51e-04 | 27 | 52 | 2 | 28167773 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 8.87e-04 | 754 | 52 | 6 | 33060197 | |
| Pubmed | 9.65e-04 | 129 | 52 | 3 | 23022380 | ||
| Pubmed | 9.92e-04 | 31 | 52 | 2 | 19690177 | ||
| Pubmed | Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes. | 1.06e-03 | 32 | 52 | 2 | 21546767 | |
| Pubmed | 1.06e-03 | 32 | 52 | 2 | 34288113 | ||
| Pubmed | 1.12e-03 | 33 | 52 | 2 | 19714462 | ||
| Pubmed | 1.12e-03 | 33 | 52 | 2 | 25582440 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 1.18e-03 | 1425 | 52 | 8 | 30948266 | |
| Pubmed | Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. | 1.19e-03 | 34 | 52 | 2 | 12791985 | |
| Pubmed | A quantitative telomeric chromatin isolation protocol identifies different telomeric states. | 1.19e-03 | 34 | 52 | 2 | 24270157 | |
| Pubmed | 1.26e-03 | 1440 | 52 | 8 | 30833792 | ||
| Pubmed | Links between alpha-catenin, NF-kappaB, and squamous cell carcinoma in skin. | 1.26e-03 | 35 | 52 | 2 | 16452166 | |
| Pubmed | 1.40e-03 | 147 | 52 | 3 | 29576527 | ||
| Pubmed | Isolation and Characterization of Fetal Leydig Progenitor Cells of Male Mice. | 1.41e-03 | 37 | 52 | 2 | 26697723 | |
| Interaction | KLRB1 interactions | 1.20e-05 | 57 | 50 | 4 | int:KLRB1 | |
| GeneFamily | Ubiquitin specific peptidases | 2.38e-04 | 56 | 39 | 3 | 366 | |
| GeneFamily | CD molecules|Mucins | 9.28e-04 | 21 | 39 | 2 | 648 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.76e-06 | 193 | 51 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-06 | 193 | 51 | 5 | 9d7bc71c4ae871aad057d3beb6e06c929ae17203 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-06 | 195 | 51 | 5 | 23ced69fd904f1d4114b1a7f99f4b5f65ea8824b | |
| ToppCell | tumor_Lung-Epithelial_cells-tS1|Epithelial_cells / Location, Cell class and cell subclass | 3.05e-06 | 197 | 51 | 5 | 7190143468939cf26c069d125a5e88e4bf026299 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D3|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.18e-05 | 143 | 51 | 4 | 10473c0f030d5ff760263042dc4b584787cb4a7f | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 170 | 51 | 4 | 064786c1f1ad7665358964765910b0ad46d14685 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 170 | 51 | 4 | 6725747df336697708b94999b3ebb40f1721da16 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.38e-05 | 171 | 51 | 4 | 10492832db8ebc3cf85503c441f33bd94df9458e | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.38e-05 | 171 | 51 | 4 | 7c0a1b0676f6749ee710c6bdeca6d6f7fac79b69 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-NK_CD56bright|Int-URO / Disease, Lineage and Cell Type | 4.69e-05 | 174 | 51 | 4 | 93c7acd5941a5f235ec4c57461f78ee2871e7336 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.79e-05 | 175 | 51 | 4 | 8fb8c4b9e2d9b7d737f59cd9bd3dc2bca5a8dfc4 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.01e-05 | 177 | 51 | 4 | 0e74980a7686c31fcf1476b8f19a3392541df240 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-05 | 179 | 51 | 4 | fc9f44fb81da0d381a5141a95a005e66a0be28cc | |
| ToppCell | facs-Bladder-nan-24m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-05 | 179 | 51 | 4 | 9152d92bb96e65d43de54e933494f0d08ae02c4f | |
| ToppCell | IPF-Lymphoid-ILC_B|IPF / Disease state, Lineage and Cell class | 5.35e-05 | 180 | 51 | 4 | b2fde7cd140a3ede8cac2d06f1f72eb438def82e | |
| ToppCell | IPF-Lymphoid-ILC_B|World / Disease state, Lineage and Cell class | 5.35e-05 | 180 | 51 | 4 | a4de9f67a7ab4b3c17247139fc584e13678411b4 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 5.35e-05 | 180 | 51 | 4 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.46e-05 | 181 | 51 | 4 | 1fa882ee66e6f835acf3f293fd24dc7f8b1eff99 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-05 | 183 | 51 | 4 | 268fc48ffd88e19c9dcd1af32b635256fc915742 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-05 | 183 | 51 | 4 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | P07-Epithelial-airway_epithelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.82e-05 | 184 | 51 | 4 | a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-club_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.82e-05 | 184 | 51 | 4 | ab469b9e06212462cbe2e4db8775c6778db855e6 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_urothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-05 | 186 | 51 | 4 | 8589d55f7f778442bf31cd4eb1fdaa632f1b7ab0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-05 | 192 | 51 | 4 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 7.15e-05 | 194 | 51 | 4 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 7.15e-05 | 194 | 51 | 4 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.15e-05 | 194 | 51 | 4 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.29e-05 | 195 | 51 | 4 | d700e959e060932e3854a9cf294799465efbe18b | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-05 | 195 | 51 | 4 | f7a4ce7076148389471678bcc5349df8b72b653e | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 7.44e-05 | 196 | 51 | 4 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.58e-05 | 197 | 51 | 4 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD8-gdT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.73e-05 | 198 | 51 | 4 | 9dc91a1101eef649a301f0147ecd5c028a9c2b12 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.89e-05 | 199 | 51 | 4 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.89e-05 | 199 | 51 | 4 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.89e-05 | 199 | 51 | 4 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-gd_T|ICU-NoSEP / Disease, condition lineage and cell class | 8.04e-05 | 200 | 51 | 4 | 2c2cea7691c340912f6ad77667a580a071eaeb8b | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-MAIT|Multiple_Sclerosis / Disease, condition lineage and cell class | 8.04e-05 | 200 | 51 | 4 | 10120f474ac3de10fc8e66158969415bd3f8c1da | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.58e-04 | 108 | 51 | 3 | 63d45cc3ee149a7baf255b70409f8ea54c56157b | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3-Tnr|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.58e-04 | 108 | 51 | 3 | d57eeda825b6e0e64bae185896ae7eea6a2a50e9 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.58e-04 | 108 | 51 | 3 | c2aa6bf8554bfb6b0f9c5f6658601c6cf7c8bdbc | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.58e-04 | 108 | 51 | 3 | db8472616886c6195f8c27c00f00133a9c10691d | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.64e-04 | 132 | 51 | 3 | 46c80eab16a70da9f363a9fbdf50bccab0b287d7 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.64e-04 | 132 | 51 | 3 | a022c3c41654166cb106f27dc54fa88e8c40f898 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.85e-04 | 134 | 51 | 3 | d29ac8152dc581c0da2430d06cd259ac0eded808 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.85e-04 | 134 | 51 | 3 | 459c39df15d3cf9144ce7827e8d14830d31353bb | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.85e-04 | 134 | 51 | 3 | d065449ca3679e4818b74fb7302cc7f1ce62f691 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.85e-04 | 134 | 51 | 3 | 0be389f416818a22e80098dd809fdf45b14171e8 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.62e-04 | 141 | 51 | 3 | 3fa3d2a8ebd9c285168ecea6db9cad74d3a3e85a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.62e-04 | 141 | 51 | 3 | cabb5b8c0874813c713508af2ac620ab0d61ab6f | |
| ToppCell | Control-NK|World / Disease group and Cell class | 5.86e-04 | 143 | 51 | 3 | fe08adc9472dfd4242497d6c614d0490713261da | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.10e-04 | 145 | 51 | 3 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.60e-04 | 149 | 51 | 3 | 3980fa4f1986a2f164a1826ea043fb71f1d756cd | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.73e-04 | 150 | 51 | 3 | 53de595376a9fc92491dfd58ff25938b0bf79903 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.73e-04 | 150 | 51 | 3 | 580ed7733857402345f43ca2623f72cdd1edf22c | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.73e-04 | 150 | 51 | 3 | e4b40b3243ed26d0c46bf196ac06e148834e7ed2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.86e-04 | 151 | 51 | 3 | f5ae450e3daa10540ca8437d05efe2d86ac70960 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.12e-04 | 153 | 51 | 3 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.12e-04 | 153 | 51 | 3 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.12e-04 | 153 | 51 | 3 | edf5d026e8e4c685b7c369d70894741bb2cd568e | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.12e-04 | 153 | 51 | 3 | 5fbb90b8477f9fdabf3be19efd3068fbf70abee6 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.12e-04 | 153 | 51 | 3 | 2c46183481e6d5a7fa190a743062509465f88e56 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.12e-04 | 153 | 51 | 3 | 3240d4d690335ba22317b1f3d33f9ea069e93838 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.12e-04 | 153 | 51 | 3 | decc4f3098a9374a6b65c015a9d36380986290bf | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.12e-04 | 153 | 51 | 3 | 36a28805c0545c2f410c74a6ca0a70d840e75715 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.12e-04 | 153 | 51 | 3 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.26e-04 | 154 | 51 | 3 | ec56b7fb88e39041416c384f371c767f3b4e92fa | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.40e-04 | 155 | 51 | 3 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.40e-04 | 155 | 51 | 3 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-04 | 156 | 51 | 3 | 5caefdc6cc86f2ac52abe8c8da821db14f476915 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-04 | 156 | 51 | 3 | 758f57dc10fc5cad200bf5b310c10ec9b1405f23 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.68e-04 | 157 | 51 | 3 | 0362c04b7b0b5017964b3a73ee678ae53e7238d7 | |
| ToppCell | COVID-19_Severe-NK_CD56bright|World / disease group, cell group and cell class | 7.68e-04 | 157 | 51 | 3 | 9dcbabb377da7e93ec9f9abf09576a92877a7e02 | |
| ToppCell | 368C-Lymphocytic-NK_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.68e-04 | 157 | 51 | 3 | ef5c0ace4cd500b6cc50fb7076298f3d3543b40c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-T_lymphocytic-mature_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.68e-04 | 157 | 51 | 3 | 3aa12913410925d577205cb6f1f5ae6bea20d93f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.82e-04 | 158 | 51 | 3 | 7274f020c0ecf216da4b6689c62bc5f49c29b6f3 | |
| ToppCell | severe_COVID-19-NK_CD56bright|severe_COVID-19 / disease group, cell group and cell class (v2) | 7.82e-04 | 158 | 51 | 3 | c2e8d96fc29aa2388b92b4fd81d2726e1f7a053f | |
| ToppCell | COVID-19_Severe-NK_CD56bright|COVID-19_Severe / disease group, cell group and cell class | 7.96e-04 | 159 | 51 | 3 | 9e2067f0d76769717f7048dab505fadd36bbb83e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.96e-04 | 159 | 51 | 3 | 235ed12053b337aca5abc2ce8727332b4ae3f8ae | |
| ToppCell | IIF-Lymphocyte-T_NK-ILC|IIF / Disease, Lineage and Cell Type | 7.96e-04 | 159 | 51 | 3 | 55e4f21548f480ca414c00cbff5ec3b13bafd271 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-ILC3|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.26e-04 | 161 | 51 | 3 | 584e44e6048c2678eb72cd23a86f48f2466c5da4 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.26e-04 | 161 | 51 | 3 | 3e5a125a25d55bf27652f456239b00b315d54d91 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 8.41e-04 | 162 | 51 | 3 | e5fc80ab19d513af6a7e677a5e67bfebca2e963b | |
| ToppCell | mild-Myeloid-Eosinophils|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.56e-04 | 163 | 51 | 3 | 7c57d541a88e9afa079e95b8a6ecdea60a0c6aaa | |
| ToppCell | -Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 8.71e-04 | 164 | 51 | 3 | 2d65f025f921a5327bfd8d260815baaed00ef3fa | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.86e-04 | 165 | 51 | 3 | a379fa981db51bec01adea7b1e55e133e15ec383 | |
| ToppCell | COPD-Lymphoid-ILC_B|COPD / Disease state, Lineage and Cell class | 9.02e-04 | 166 | 51 | 3 | 7609671e453280c6e522e9f659c06aab8be81945 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.18e-04 | 167 | 51 | 3 | ded4d6cccd3660662f12cf5a512de31d26325f1b | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.18e-04 | 167 | 51 | 3 | 102b3d160a44c8623fab1fd10e9054178c42a78b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.34e-04 | 168 | 51 | 3 | 9e7b4b9b977e90e083f5164013e79df8bc2d492e | |
| ToppCell | PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.34e-04 | 168 | 51 | 3 | 2ec53f91de3bff8a106430a78b81ee6870f0c55e | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.34e-04 | 168 | 51 | 3 | fa7c0303918cea04e3f4c4f3cb079be19004d214 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.34e-04 | 168 | 51 | 3 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_T-T_NK-Treg|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.34e-04 | 168 | 51 | 3 | 99117480687e2b8e7521d3ae9e020791757ec48e | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.34e-04 | 168 | 51 | 3 | 7edcab103c69e928d5c19a0d218ffb3ae32f9e70 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.50e-04 | 169 | 51 | 3 | 41ad349806b279fbe1374b7e3cc7f146a11adb44 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.50e-04 | 169 | 51 | 3 | 20fbf78382fb0ba9a63ab1aa0abc615476994ac5 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.50e-04 | 169 | 51 | 3 | e9c0e0f4c421c7bdbf1a7e33002f3cf22ea307cb | |
| ToppCell | COPD-Lymphoid-ILC_B|World / Disease state, Lineage and Cell class | 9.50e-04 | 169 | 51 | 3 | 01987c00e0e398eb734613a55e71b4a2b1f0bb21 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.50e-04 | 169 | 51 | 3 | d375a1df1ecc938f66bad92e54b8cda26ca9c472 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.50e-04 | 169 | 51 | 3 | 58f805c0be507bd5fadc9ea3555032daabbc8ab8 | |
| Disease | Metastatic melanoma | 9.45e-05 | 54 | 48 | 3 | C0278883 | |
| Disease | Asthma | 3.04e-04 | 80 | 48 | 3 | C0004096 | |
| Disease | Malignant neoplasm of breast | 3.10e-04 | 1074 | 48 | 8 | C0006142 | |
| Disease | breast cancer (implicated_via_orthology) | 7.59e-04 | 25 | 48 | 2 | DOID:1612 (implicated_via_orthology) | |
| Disease | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | 7.72e-04 | 110 | 48 | 3 | EFO_0803335 | |
| Disease | mosquito bite reaction itch intensity measurement | 1.22e-03 | 129 | 48 | 3 | EFO_0008377 | |
| Disease | choline measurement | 1.25e-03 | 130 | 48 | 3 | EFO_0010116 | |
| Disease | invasive ductal carcinoma (is_marker_for) | 1.94e-03 | 40 | 48 | 2 | DOID:3008 (is_marker_for) | |
| Disease | heart rate response to exercise | 2.24e-03 | 43 | 48 | 2 | EFO_0009184 | |
| Disease | Malignant Head and Neck Neoplasm | 2.35e-03 | 44 | 48 | 2 | C0278996 | |
| Disease | Alcohol Use Disorder | 2.35e-03 | 44 | 48 | 2 | C0001956 | |
| Disease | uric acid measurement | 3.06e-03 | 610 | 48 | 5 | EFO_0004761 | |
| Disease | Peripheral Nervous System Diseases | 3.51e-03 | 54 | 48 | 2 | C4721453 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QHKKRKRMLSSSSEM | 176 | Q9BXU7 | |
| MKTHSMIDSSLSKIA | 186 | P15514 | |
| TTLSKKASTVHMMLQ | 3041 | Q9NR09 | |
| ERITQVAKRKMMLTH | 1156 | Q8TDI0 | |
| FLMVTLHKMIRSSSV | 1021 | O94910 | |
| DKLTILRMAVSHMKS | 101 | Q9HBZ2 | |
| HTTTRTQMEMLTKDK | 531 | Q92878 | |
| SEKQALMSELKIMTH | 636 | P16234 | |
| SKVNLMQHMKLSTSR | 1271 | Q9NVI1 | |
| MSLDNTMKRHTEKST | 3821 | Q9NU22 | |
| LIEVKFSHLSRNMTM | 306 | P30419 | |
| KTMMELRSLDTQKAT | 221 | O95944 | |
| SIRSLKSDMMSHLVK | 136 | P33992 | |
| TMNSEKSMHRKSTEL | 31 | Q8TD10 | |
| IFHSTKITSKHVKMM | 141 | P43088 | |
| DTTMKVHIKRPEMTS | 3306 | Q02505 | |
| KHMSLLADLKTMVET | 521 | Q07343 | |
| LTRLATSMAKMHIFQ | 2266 | Q6ZR08 | |
| KDSQMKSIISRLMAV | 1046 | Q9UJF2 | |
| MHKMINTDLSRILKS | 281 | P36578 | |
| VGHQKKIMSSIQTMR | 971 | Q15375 | |
| TLSMSTHFKMLKKLV | 2236 | Q13535 | |
| SMKGLRMTIAKHTIT | 301 | Q7Z3S7 | |
| FQHVSLMTLDTIMKS | 186 | Q5TCH4 | |
| KTMRVHQKMTYSSKV | 81 | Q494V2 | |
| MSKMVSRRNVKDSHE | 86 | P0C5K7 | |
| VVKMTQLILKHMESR | 161 | P37058 | |
| KKRKETMSSTRQEMT | 771 | P28827 | |
| TTMKVHIKRPEMTSS | 1221 | Q9H195 | |
| MLKNKTRILVTHSMS | 816 | P33527 | |
| NMTGKMKLRNTVHLS | 161 | P59544 | |
| SMSNHTKERVTMTKV | 11 | Q15208 | |
| SKIHMQEMELKRTGS | 461 | Q96D71 | |
| MMQRIKKTETETSLH | 416 | Q03181 | |
| TMKAKHATMLLTVTE | 5806 | Q8NF91 | |
| MNKSIHIVVTMAKSL | 56 | Q13291 | |
| MKHCSKIRVIDISMI | 281 | P21108 | |
| KLTVLRMAVQHMKTL | 111 | O00327 | |
| MNKVTEKTHRVLRVM | 61 | Q3KNT9 | |
| MASINRTIEIMKKHG | 1 | Q537H7 | |
| HSVNRLAMETRKVMK | 676 | Q7Z3J2 | |
| ILTHERVLQMSKMLS | 306 | Q9Y2P5 | |
| STKSMMEVERKLAHR | 411 | Q76KD6 | |
| HLPMSKLTIKSEMRS | 121 | A2RTY3 | |
| VEKMKSMSQLAVLSR | 1216 | Q96K76 | |
| LMSAVMKHGSSITRL | 266 | Q96G79 | |
| FKTTLMNTLMDVLRH | 46 | Q3SXZ7 | |
| IMKTLKKSHESDTMS | 426 | Q6ZT12 | |
| IVHTEKVNMMSLTVL | 116 | B7Z8K6 | |
| MKHKTTLLELQKMFT | 1931 | Q70CQ2 | |
| LMEVMQKRSKAIHSS | 471 | O00401 | |
| SLSASHMETTMKLLK | 466 | Q13769 | |
| HMETTMKLLKTRVQS | 471 | Q13769 | |
| MKAKRSHQAVIMSTS | 1 | Q9NR00 |